Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
By
Beryl B. Cummings,
Jamie L. Marshall,
Taru Tukiainen,
Monkol Lek,
Sandra Donkervoort,
A. Reghan Foley,
Veronique Bolduc,
Leigh Waddell,
Sarah Sandaradura,
Gina O’Grady,
Elicia Estrella,
Hemakumar M Reddy,
Fengmei Zhao,
Ben Weisburd,
Konrad Karczewski,
Anne H. O’Donnell-Luria,
Daniel Birnbaum,
Anna Sarkozy,
Ying Hu,
Hernan Gonorazky,
Kristl Claeys,
Himanshu Joshi,
Adam Bournazos,
Emily C. Oates,
Roula Ghaoui,
Mark Davis,
Nigel Laing,
Ana Topf,
GTEx Consortium,
Peter B Kang,
Alan Beggs,
Kathryn N North,
Volker Straub,
James Dowling,
Francesco Muntoni,
Nigel F Clarke,
Sandra T Cooper,
Carsten G Bonnemann,
Daniel G MacArthur
Posted 08 Sep 2016
bioRxiv DOI: 10.1101/074153
(published DOI: 10.1126/scitranslmed.aal5209)
Exome and whole-genome sequencing are becoming increasingly routine approaches in Mendelian disease diagnosis. Despite their success, the current diagnostic rate for genomic analyses across a variety of rare diseases is approximately 25-50% [1-4]. Here, we explore the utility of transcriptome sequencing (RNA-seq) as a complementary diagnostic tool in a cohort of 50 patients with genetically undiagnosed rare neuromuscular disorders. We describe an integrated approach to analyze patient muscle RNA-seq, leveraging an analysis framework focused on the detection of transcript-level changes that are unique to the patient compared to over 180 control skeletal muscle samples. We demonstrate the power of RNA-seq to validate candidate splice-disrupting mutations and to identify splice-altering variants in both exonic and deep intronic regions, yielding an overall diagnosis rate of 35%. We also report the discovery of a highly recurrent de novo intronic mutation in COL6A1 that results in a dominantly acting splice-gain event, disrupting the critical glycine repeat motif of the triple helical domain. We identify this pathogenic variant in a total of 27 genetically unsolved patients in an external collagen VI-like dystrophy cohort, thus explaining approximately 25% of patients clinically suggestive of collagen VI dystrophy in whom prior genetic analysis is negative. Overall, this study represents the largest systematic application of transcriptome sequencing to rare disease diagnosis to date and highlights its utility for the detection and interpretation of variants missed by current standard diagnostic approaches.
Download data
- Downloaded 5,426 times
- Download rankings, all-time:
- Site-wide: 1,425 out of 118,387
- In genomics: 155 out of 6,435
- Year to date:
- Site-wide: 28,181 out of 118,387
- Since beginning of last month:
- Site-wide: 34,821 out of 118,387
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!